共 185 条
[1]
Xie Y(2018)Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness Theranostics 8 4305-4320
[2]
Wang Y(2018)Cholangiocarcinoma—evolving concepts and therapeutic strategies Nat Rev Clin Oncol 15 95-111
[3]
Li J(2016)Surgical therapy of cholangiocarcinoma Visc Med 32 422-426
[4]
Hang Y(2019)MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment Cell Death Dis 10 120-4144
[5]
Jaramillo L(2017)Update on the diagnosis and treatment of cholangiocarcinoma Curr Gastroenterol Rep 19 2-594
[6]
Wehrkamp CJ(2013)Sox proteins: regulators of cell fate specification and differentiation Development 140 4129-187
[7]
Rizvi S(2014)SOX1 down-regulates beta-catenin and reverses malignant phenotype in nasopharyngeal carcinoma Mol Cancer 13 257-2287
[8]
Khan SA(2004)Sox1 acts through multiple independent pathways to promote neurogenesis Dev Biol 269 580-175
[9]
Hallemeier CL(2018)BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma Nat Commun 9 3327-4610
[10]
Kelley RK(2019)Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype Cancer Lett 444 175-840